@stockstoearn: BREAKING: Moderna (MRNA) becomes the S&P 500’s best-performing stock of the year, taking the crown from SanDisk (SNDK). Shares of the pharmaceutical company have surged nearly 600% so far this year. The single biggest catalyst for the rally was the announcement of successful Phase 3 trial results for its personalized mRNA cancer vaccine, developed in partnership with Merck. On Oct. 9, Moderna officially joined the Nasdaq-100 Index, forcing index funds to buy shares to match the index’s new weighting. #stockstoearn #goviral #fyp #stocks #sndk

stockstoearn

Open In TikTok:

Region: US

Wednesday 14 October 2026 03:36:08 GMT